Genetic/JJ
Architecture/NN
of/IN
Transcription/NN
and/CC
Chromatin/NN
Regulation/NN
./.
====================
DNA/NN
microarray/NN
and/CC
next-generation/NN
sequencing/NN
provide/VBP
data/NNS
that/IN
can/MD
be/VB
used/VBN
for/IN
the/DT
genetic/JJ
analysis/NN
of/IN
multiple/JJ
quantitative/JJ
traits/VBZ
such/JJ
as/IN
gene/NN
expression/NN
levels/NNS
,/,
transcription/NN
factor/NN
binding/NN
profiles/NNS
,/,
and/CC
epigenetic/JJ
signatures/NNS
./.
====================
In/IN
particular/JJ
,/,
chromatin/NN
opening/VBG
is/VBZ
tightly/RB
coupled/VBN
with/IN
gene/NN
transcription/NN
./.
====================
To/TO
understand/VB
how/WRB
these/DT
two/CD
processes/NNS
are/VBP
genetically/RB
regulated/VBN
and/CC
associated/VBN
with/IN
each/DT
other/JJ
,/,
we/PRP
examined/VBD
the/DT
changes/NNS
of/IN
chromatin/NN
accessibility/NN
and/CC
gene/NN
expression/NN
in/IN
response/NN
to/TO
genetic/JJ
variation/NN
by/IN
means/NNS
of/IN
quantitative/JJ
trait/NN
loci/NNS
mapping/VBG
./.
====================
Regulatory/JJ
patterns/NNS
commonly/RB
observed/VBN
in/IN
yeast/NN
and/CC
human/JJ
across/IN
different/JJ
technical/JJ
platforms/NNS
and/CC
experimental/JJ
designs/NNS
suggest/VBP
a/DT
higher/JJR
genetic/JJ
complexity/NN
of/IN
transcription/NN
regulation/NN
in/IN
contrast/NN
to/TO
a/DT
more/RBR
robust/JJ
genetic/JJ
architecture/NN
of/IN
chromatin/NN
regulation/NN
./.
====================
Quantitative/JJ
trait/VBP
loci/NNS
(/(
QTL/NN
)/)
mapping/NN
has/VBZ
been/VBN
widely/RB
used/VBN
to/TO
discover/JJ
underlying/VBG
genetic/JJ
factors/NNS
that/WDT
can/MD
explain/VB
particular/JJ
phenotypes/NNS
of/IN
interest/NN
./.
====================
Thanks/NNS
to/TO
DNA/NN
microarray/NN
technology/NN
,/,
the/DT
expression/NN
phenotype/NN
of/IN
thousands/NNS
of/IN
genes/NNS
was/VBD
associated/VBN
with/IN
the/DT
genotypes/NNS
across/IN
the/DT
whole/JJ
genome/NN
in/IN
expression/NN
QTL/NN
mapping/VBG
[/(
1234567/CD
]/)
./.
====================
Recent/JJ
advent/JJ
of/IN
next-generation/NN
sequencing/NN
technology/NN
has/VBZ
enabled/VBN
a/DT
genetic/JJ
profiling/VBG
of/IN
chromatin/NN
traits/VBZ
as/IN
well/RB
as/IN
more/RBR
in-depth/IN
analyses/NNS
of/IN
gene/NN
expression/NN
variation/NN
./.
====================
Especially/RB
,/,
the/DT
mechanisms/NNS
controlling/VBG
chromatin/NN
accessibility/NN
have/VBP
been/VBN
of/IN
particular/JJ
interest/NN
because/IN
of/IN
their/PRP$
importance/NN
in/IN
a/DT
wide/JJ
spectrum/NN
of/IN
DNA/NN
regulation/NN
processes/NNS
./.
====================
For/IN
example/NN
,/,
Degner/NN
et/FW
al/JJ
./.
====================
[/(
8/CD
]/)
utilized/VBD
DNaseI/NN
hypersensitivity/NN
assay/NN
coupled/VBN
with/IN
high-throughput/JJ
sequencing/NN
(/(
DNase-seq/NN
)/)
to/TO
map/VB
genome-wide/NN
chromatin/NN
accessibility/NN
to/TO
the/DT
genotypes/NNS
across/IN
70/CD
human/JJ
individuals/NNS
,/,
for/IN
which/WDT
a/DT
previous/JJ
RNA-sequencing/JJ
(/(
RNA-seq/NN
)/)
-based/JJ
expression/NN
QTL/NN
study/NN
revealed/VBD
new/JJ
insights/NNS
into/IN
the/DT
genetic/JJ
regulation/NN
of/IN
transcription/NN
[/(
5/CD
]/)
./.
====================
In/IN
yeast/NN
,/,
expression/NN
QTL/NN
mapping/VBG
has/VBZ
been/VBN
performed/VBN
for/IN
the/DT
genetic/JJ
dissection/NN
of/IN
transcription/NN
regulation/NN
in/IN
a/DT
cross/JJ
between/IN
two/CD
parental/JJ
strains/NNS
of/IN
Saccharomyces/NN
cerevisiae/NN
(/(
BY4716/CD
and/CC
RM11-1a/NN
)/)
based/VBN
on/IN
DNA/NN
microarrays/NNS
[/(
1291011/CD
]/)
./.
====================
In/IN
order/NN
to/TO
generate/VB
a/DT
matched/JJ
dataset/NN
of/IN
chromatin/NN
accessibility/NN
for/IN
this/DT
set/NN
of/IN
yeast/NN
individuals/NNS
,/,
we/PRP
carried/VBD
out/RP
Formaldehyde-Assisted/JJ
Isolation/NN
of/IN
Regulatory/JJ
Elements/NNS
followed/VBN
by/IN
sequencing/VBG
(/(
FAIRE-seq/NN
)/)
for/IN
a/DT
total/JJ
of/IN
96/CD
segregants/NNS
from/IN
the/DT
cross/JJ
of/IN
BY4716/NN
and/CC
RM11-1a/NN
[/(
12/CD
]/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
sought/VBD
to/TO
dissect/VB
the/DT
genetic/JJ
architecture/NN
of/IN
the/DT
regulation/NN
of/IN
gene/NN
expression/NN
and/CC
chromatin/NN
accessibility/NN
by/IN
analysing/VBG
previous/JJ
data/NNS
generated/VBD
in/IN
yeast/NN
and/CC
human/JJ
based/VBN
on/IN
different/JJ
technical/JJ
platforms/NNS
and/CC
experimental/JJ
designs/NNS
./.
====================
Our/PRP$
main/JJ
goal/NN
was/VBD
to/TO
find/VB
differences/NNS
in/IN
the/DT
overall/JJ
regulatory/JJ
structure/NN
between/IN
open/JJ
chromatin/NN
and/CC
gene/NN
expression/NN
./.
====================
We/PRP
were/VBD
also/RB
interested/VBD
to/TO
determine/VB
whether/IN
the/DT
two/CD
distant/JJ
species/NNS
,/,
namely/RB
yeast/NN
and/CC
human/JJ
,/,
would/MD
be/VB
different/JJ
in/IN
genetic/JJ
regulatory/JJ
architecture/NN
and/CC
to/TO
estimate/VB
the/DT
effect/NN
of/IN
the/DT
technical/JJ
or/CC
experimental/JJ
differences/NNS
in/IN
genotyping/VBG
and/CC
measuring/VBG
the/DT
quantitative/JJ
traits/VBZ
./.
====================
Processing/VBG
of/IN
human/JJ
genotype/NN
data/NNS
====================
Genotype/NN
data/NNS
from/IN
the/DT
HapMap/NN
project/VB
[/(
13/CD
]/)
and/CC
1000/CD
Genomes/NNS
Project/JJ
[/(
14/CD
]/)
for/IN
70/CD
Yoruba/NN
(/(
YRI/NN
)/)
lymphoblastoid/JJ
cell/NN
lines/NNS
were/VBD
used/VBN
for/IN
DNase-seq/NN
analysis/NN
[/(
8/CD
]/)
./.
====================
The/DT
genotype/NN
of/IN
each/DT
single/JJ
nucleotide/NN
polymorphism/NN
(/(
SNP/NN
)/)
locus/NN
was/VBD
estimated/VBN
based/VBN
on/IN
the/DT
Bayesian/JJ
framework/NN
by/IN
means/NNS
of/IN
the/DT
BIMBAM/NN
tool/NN
[/(
15/CD
]/)
and/CC
the/DT
genotype/NN
estimates/NNS
were/VBD
made/VBN
available/JJ
at/IN
http/NN
:/:
//eqtl.uchicago.edu/dsQTL_data/GENOTYPES//JJ
./.
====================
We/PRP
first/RB
selected/VBN
2,157,286/CD
genetic/JJ
markers/NNS
(/(
SNPs/NNS
)/)
with/IN
the/DT
minor/JJ
allele/NN
frequency/NN
greater/JJR
than/IN
30/CD
%/NN
./.
====================
To/TO
reduce/VB
complexity/NN
and/CC
ease/JJ
interpretation/NN
,/,
we/PRP
focused/VBD
on/IN
the/DT
genetic/JJ
variants/NNS
that/IN
can/MD
change/VB
the/DT
function/NN
of/IN
the/DT
protein/NN
(/(
non-synonymous/JJ
SNPs/NNS
)/)
or/CC
the/DT
abundance/NN
of/IN
the/DT
protein/NN
(/(
SNPs/NNS
associated/VBN
with/IN
the/DT
expression/NN
level/NN
of/IN
a/DT
nearby/JJ
gene/NN
)/)
./.
====================
The/DT
SIFT/NN
tool/NN
[/(
16/CD
]/)
was/VBD
used/VBN
to/TO
identify/VB
non-synonymous/JJ
SNPs/NNS
./.
====================
We/PRP
performed/VBD
expression/NN
QTL/NN
mapping/VBG
as/IN
described/VBN
below/IN
and/CC
identified/VBD
SNPs/NNS
that/DT
were/VBD
associated/VBN
(/(
p/NN
</JJR
10-5/CD
)/)
in/IN
cis/NN
(/(
within/IN
200/CD
kb/NN
from/IN
the/DT
nearest/JJ
gene/NN
)/)
./.
====================
Taken/VBN
together/RB
,/,
7,211/CD
SNPs/NNS
were/VBD
identified/VBN
for/IN
QTL/NN
mapping/NN
./.
====================
Processing/VBG
of/IN
human/JJ
gene/NN
expression/NN
data/NNS
====================
RNA-seq/NN
data/NNS
for/IN
69/CD
YRI/NN
lymphoblastoid/JJ
cell/NN
lines/NNS
[/(
5/CD
]/)
were/VBD
downloaded/VBN
from/IN
http/NN
:/:
//eqtl.uchicago.edu/RNA_Seq_data/results/NNS
./.
====================
A/DT
total/JJ
of/IN
18,147/CD
genes/NNS
were/VBD
used/VBN
after/IN
normalization/NN
to/TO
zero/CD
mean/NN
and/CC
unit/NN
variance/NN
./.
====================
Processing/VBG
of/IN
human/JJ
chromatin/NN
accessibility/NN
data/NNS
====================
DNase-seq/NN
data/NNS
for/IN
70/CD
YRI/NN
lymphoblastoid/JJ
cell/NN
lines/NNS
[/(
8/CD
]/)
were/VBD
downloaded/VBN
from/IN
http/NN
:/:
//eqtl.uchicago.edu/dsQTL_data/MAPPED_READS//JJ
./.
====================
Sequence/NN
reads/VBZ
from/IN
multiple/JJ
replicates/VBZ
for/IN
each/DT
sample/NN
were/VBD
combined/VBN
and/CC
F-Seq/NN
[/(
17/CD
]/)
was/VBD
run/JJ
to/TO
identify/VB
the/DT
peaks/NNS
of/IN
the/DT
reads/VBZ
from/IN
each/DT
sample/NN
./.
====================
Statistical/JJ
significance/NN
of/IN
the/DT
peak/NN
was/VBD
determined/VBN
by/IN
fitting/VBG
the/DT
data/NNS
to/TO
a/DT
gamma/NN
distribution/NN
to/TO
obtain/VB
the/DT
p-value/JJ
(/(
script/NN
obtained/VBN
from/IN
the/DT
F-Seq/NN
authors/NNS
)/)
./.
====================
p/NN
</JJR
10-3/CD
was/VBD
used/VBN
to/TO
identify/VB
significant/JJ
peaks/NNS
from/IN
each/DT
sample/NN
./.
====================
The/DT
overlapping/VBG
peaks/VBZ
across/IN
the/DT
YRI/NN
individuals/NNS
were/VBD
merged/VBN
into/IN
a/DT
single/JJ
peak/NN
by/IN
using/VBG
the/DT
mergeBED/NN
command/CC
of/IN
BEDTools/NNS
[/(
18/CD
]/)
,/,
resulting/VBG
in/IN
a/DT
total/JJ
of/IN
265,130/CD
accessible/JJ
chromatin/NN
regions/NNS
./.
====================
For/IN
each/DT
sample/NN
,/,
the/DT
number/NN
of/IN
the/DT
DNase-seq/NN
reads/VBZ
mapped/VBD
to/TO
each/DT
region/NN
was/VBD
counted/VBN
and/CC
the/DT
read/JJ
count/NN
was/VBD
normalized/VBN
as/IN
previously/RB
suggested/VBD
[/(
1920/CD
]/)
to/TO
obtain/VB
normalized/VBN
chromatin/NN
accessibility/NN
,/,
which/WDT
was/VBD
then/RB
further/RB
normalized/VBN
to/TO
zero/CD
mean/JJ
and/CC
unit/NN
variance/RB
across/IN
the/DT
YRI/NN
samples/NNS
./.
====================
Accessible/JJ
regions/NNS
falling/VBG
on/IN
promoters/NNS
or/CC
enhancers/NNS
were/VBD
identified/VBN
based/VBN
on/IN
chromatin/NN
annotation/NN
by/IN
Ernst/JJ
et/FW
al/JJ
./.
====================
[/(
21/CD
]/)
./.
====================
A/DT
total/JJ
of/IN
45,781/CD
chromatin/NN
regions/NNS
were/VBD
found/VBN
to/TO
reside/VB
in/IN
active/JJ
promoters/NNS
,/,
weak/JJ
promoters/NNS
,/,
poised/VBD
promoters/NNS
,/,
strong/JJ
enhancers/NNS
,/,
and/CC
weak/JJ
enhancers/NNS
annotated/JJ
in/IN
the/DT
GM12878/NN
lymphoblastoid/JJ
cell/NN
line/NN
./.
====================
Processing/VBG
of/IN
yeast/NN
data/NNS
====================
Genotype/JJ
and/CC
gene/NN
expression/NN
microarray/NN
data/NNS
[/(
10/CD
]/)
used/VBN
in/IN
previous/JJ
expression/NN
QTL/NN
studies/NNS
[/(
129/CD
]/)
for/IN
>/JJR
100/CD
segregants/NNS
from/IN
a/DT
cross/JJ
between/IN
two/CD
parental/JJ
strains/NNS
of/IN
yeast/NN
(/(
BY4716/CD
and/CC
RM11-1a/NN
)/)
were/VBD
obtained/VBN
./.
====================
As/IN
previously/RB
suggested/VBD
[/(
22/CD
]/)
,/,
adjacent/JJ
genetic/JJ
markers/NNS
with/IN
less/RBR
than/IN
three/CD
genotypic/JJ
mismatches/NNS
across/IN
the/DT
yeast/NN
strains/NNS
were/VBD
merged/VBN
into/IN
the/DT
average/NN
genotype/NN
profile/NN
,/,
resulting/VBG
in/IN
1,533/CD
unique/JJ
markers/NNS
./.
====================
We/PRP
employed/VBD
the/DT
microarray/NN
dataset/NN
of/IN
normalized/VBN
expression/NN
levels/NNS
of/IN
5,352/CD
genes/NNS
as/IN
previously/RB
used/VBN
[/(
10/CD
]/)
./.
====================
FAIRE/NN
experiments/NNS
were/VBD
performed/VBN
based/VBN
on/IN
the/DT
published/VBN
protocol/NN
[/(
23/CD
]/)
./.
====================
The/DT
FAIRE-seq/NN
data/NNS
for/IN
the/DT
96/CD
yeast/NN
strains/NNS
from/IN
our/PRP$
previous/JJ
work/NN
[/(
12/CD
]/)
is/VBZ
available/JJ
at/IN
the/DT
Gene/NN
Expression/NN
Omnibus/JJ
(/(
GEO/NN
)/)
database/NN
with/IN
accession/NN
number/NN
GSE33466/NN
./.
====================
Briefly/RB
,/,
we/PRP
identified/VBD
open/JJ
chromatin/NN
regions/NNS
in/IN
96/CD
yeast/NN
segregants/NNS
by/IN
means/NNS
of/IN
F-Seq/NN
[/(
17/CD
]/)
./.
====================
The/DT
overlapping/VBG
peaks/VBZ
across/IN
the/DT
96/CD
strains/NNS
were/VBD
merged/VBN
into/IN
a/DT
single/JJ
peak/NN
by/IN
using/VBG
BEDTools/NNS
[/(
18/CD
]/)
,/,
resulting/VBG
in/IN
a/DT
total/JJ
of/IN
7,527/CD
accessible/JJ
chromatin/NN
regions/NNS
./.
====================
For/IN
each/DT
sample/NN
,/,
the/DT
number/NN
of/IN
the/DT
FAIRE-seq/NN
reads/VBZ
mapped/VBD
to/TO
each/DT
region/NN
was/VBD
counted/VBN
and/CC
the/DT
read/JJ
count/NN
was/VBD
normalized/VBN
as/IN
previously/RB
suggested/VBD
[/(
1920/CD
]/)
to/TO
obtain/VB
normalized/VBN
chromatin/NN
accessibility/NN
,/,
which/WDT
was/VBD
then/RB
further/RB
normalized/VBN
to/TO
zero/CD
mean/JJ
and/CC
unit/NN
variance/RB
across/IN
the/DT
96/CD
segregants/NNS
./.
====================
Trans-QTL/NN
analysis/NN
====================
Sixty-three/CD
human/JJ
samples/NNS
were/VBD
commonly/RB
present/JJ
in/IN
the/DT
RNA-seq/NN
[/(
5/CD
]/)
and/CC
DNase-seq/NN
[/(
8/CD
]/)
data/NNS
,/,
and/CC
96/CD
yeast/NN
segregants/NNS
in/IN
the/DT
microarray/NN
and/CC
FAIRE-seq/NN
data/NNS
./.
====================
Therefore/RB
,/,
we/PRP
used/VBD
the/DT
common/JJ
samples/NNS
for/IN
our/PRP$
QTL/NN
mapping/NN
./.
====================
Linear/JJ
regression/NN
was/VBD
carried/VBN
out/RP
leading/VBG
to/TO
2,100,341/CD
chromatin/NN
associations/NNS
and/CC
975,333/CD
expression/NN
associations/NNS
in/IN
human/JJ
,/,
and/CC
110,802/CD
chromatin/NN
linkages/NNS
and/CC
164,217/CD
expression/NN
linkages/VBZ
in/IN
yeast/NN
at/IN
p/NN
</JJR
0.01/CD
./.
====================
Genetic/JJ
markers/NNS
farther/RB
than/IN
200/CD
kb/NN
from/IN
the/DT
nearest/JJ
gene/NN
in/IN
human/JJ
and/CC
100/CD
kb/NN
in/IN
yeast/NN
were/VBD
identified/VBN
to/TO
examine/VB
regulatory/JJ
relationships/NNS
acting/VBG
in/IN
trans/JJ
./.
====================
For/IN
each/DT
trait/VBP
(/(
gene/NN
or/CC
accessible/JJ
chromatin/NN
region/NN
)/)
and/CC
regulatory/JJ
locus/NN
(/(
genetic/JJ
marker/NN
)/)
,/,
the/DT
number/NN
of/IN
associations/NNS
or/CC
linkages/NNS
was/VBD
obtained/VBN
and/CC
divided/VBN
by/IN
the/DT
total/JJ
number/NN
of/IN
associations/NNS
at/IN
a/DT
given/VBN
p-value/NN
./.
====================
For/IN
a/DT
systematic/JJ
comparative/JJ
analysis/NN
of/IN
chromatin/NN
regulation/NN
and/CC
transcription/NN
regulation/NN
,/,
we/PRP
carried/VBD
out/RP
QTL/NN
mapping/VBG
in/IN
a/DT
unified/JJ
analytical/JJ
framework/NN
by/IN
applying/VBG
the/DT
identical/JJ
statistical/JJ
methods/NNS
and/CC
criteria/NNS
for/IN
open/JJ
chromatin/NN
and/CC
gene/NN
expression/NN
data/NNS
in/IN
yeast/NN
and/CC
human/JJ
(/(
Methods/NNS
and/CC
Fig/NN
./.
====================
1/CD
)/)
./.
====================
From/IN
the/DT
human/JJ
chromatin/NN
accessibility/NN
data/NNS
[/(
8/CD
]/)
,/,
we/PRP
selected/VBD
chromatin/NN
sites/NNS
at/IN
the/DT
promoter/NN
or/CC
enhancer/NN
(/(
as/IN
defined/VBN
by/IN
Ernst/JJ
et/FW
al/JJ
./.
====================
[/(
21/CD
]/)
)/)
./.
====================
Yeast/RB
and/CC
human/JJ
QTL/NN
mapping/VBG
was/VBD
different/JJ
in/IN
the/DT
genetics/NNS
setting/VBG
(/(
linkage/NN
vs./CC
association/NN
)/)
and/CC
technical/JJ
platforms/NNS
(/(
DNA/NN
microarray/NN
vs./CC
RNA-seq/NN
and/CC
FAIRE-seq/NN
vs./CC
DNase-seq/NN
)/)
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
We/PRP
selected/VBD
significant/JJ
trans-associations/NNS
based/VBN
on/IN
the/DT
p-value/JJ
of/IN
linear/JJ
regression/NN
and/CC
then/RB
examined/VBD
the/DT
distribution/NN
of/IN
linkages/NNS
between/IN
regulatory/JJ
loci/NNS
(/(
genetic/JJ
markers/NNS
)/)
and/CC
quantitative/JJ
traits/VBZ
(/(
gene/NN
expression/NN
levels/NNS
or/CC
chromatin/NN
accessibility/NN
)/)
./.
====================
First/RB
,/,
there/EX
were/VBD
particular/JJ
regulatory/JJ
loci/NNS
that/IN
were/VBD
associated/VBN
with/IN
a/DT
large/JJ
number/NN
of/IN
target/NN
chromatin/NN
traits/VBZ
but/CC
not/RB
with/IN
gene/NN
expression/NN
traits/VBZ
both/CC
in/FW
human/JJ
and/CC
yeast/NN
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
Second/RB
,/,
expression/NN
traits/VBZ
than/IN
chromatin/NN
traits/VBZ
were/VBD
associated/VBN
with/IN
a/DT
greater/JJR
number/NN
of/IN
regulatory/JJ
loci/NNS
(/(
Fig/NN
./.
====================
3/CD
)/)
./.
====================
This/DT
trend/NN
was/VBD
consistently/RB
found/VBN
when/WRB
varying/VBG
p-values/NNS
were/VBD
used/VBN
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
Intriguingly/RB
,/,
the/DT
number/NN
of/IN
targets/NNS
for/IN
chromatin/NN
regulatory/JJ
loci/NNS
is/VBZ
more/RBR
dispersed/JJ
resulting/VBG
in/IN
outliers/NNS
with/IN
extremely/RB
many/JJ
targets/NNS
while/IN
the/DT
average/NN
number/NN
is/VBZ
lower/JJR
as/IN
compared/VBN
to/TO
the/DT
pattern/NN
of/IN
expression/NN
regulatory/JJ
loci/NNS
(/(
grey/PRP
vs./CC
white/JJ
in/IN
the/DT
upper/JJ
panel/NN
of/IN
Fig/NN
./.
====================
4/CD
)/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
the/DT
number/NN
of/IN
associated/VBN
regulatory/JJ
loci/NNS
was/VBD
much/RB
greater/JJR
for/IN
gene/NN
expression/NN
traits/VBZ
in/IN
terms/NNS
of/IN
the/DT
outliers/NNS
and/CC
average/NN
as/IN
well/RB
(/(
grey/PRP
vs./CC
white/JJ
in/IN
the/DT
lower/JJR
panel/NN
of/IN
Fig/NN
./.
====================
4/CD
)/)
./.
====================
These/DT
findings/NNS
can/MD
be/VB
interpreted/VBN
as/IN
follows/VBZ
./.
====================
There/EX
are/VBP
a/DT
few/JJ
regulatory/JJ
hotspots/NNS
that/DT
are/VBP
responsible/JJ
for/IN
a/DT
large/JJ
number/NN
of/IN
chromatin/NN
sites/NNS
./.
====================
Most/JJS
regulatory/JJ
loci/NNS
,/,
however/RB
,/,
tend/VBP
to/TO
influence/VB
fewer/JJR
chromatin/NN
traits/VBZ
than/IN
gene/NN
expression/NN
traits/VBZ
./.
====================
Different/JJ
biological/JJ
functions/NNS
are/VBP
expected/VBN
between/IN
the/DT
promiscuous/JJ
and/CC
specific/JJ
chromatin/NN
regulators/NNS
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
gene/NN
expression/NN
seems/VBZ
to/TO
be/VB
more/RBR
reactive/JJ
to/TO
genetic/JJ
variation/NN
when/WRB
judged/VBN
by/IN
the/DT
number/NN
of/IN
associated/VBN
regulatory/JJ
loci/NNS
./.
====================
This/DT
may/MD
imply/VB
that/IN
transcription/NN
processes/NNS
receive/JJ
more/RBR
regulatory/JJ
inputs/NNS
than/IN
chromatin/NN
regulation/NN
,/,
in/IN
which/WDT
case/NN
chromatin/NN
accessibility/NN
may/MD
not/RB
be/VB
a/DT
good/JJ
predictor/NN
of/IN
precise/JJ
gene/NN
expression/NN
levels/NNS
./.
====================
There/EX
was/VBD
a/DT
remarkable/JJ
consistency/NN
of/IN
the/DT
data/NNS
for/IN
two/CD
evolutionarily/RB
distant/JJ
species/NNS
across/IN
different/JJ
technical/JJ
platforms/NNS
and/CC
experimental/JJ
settings/NNS
,/,
thereby/RB
supporting/VBG
the/DT
biological/JJ
implications/NNS
of/IN
the/DT
findings/NNS
while/IN
ruling/VBG
out/IN
the/DT
possibility/NN
of/IN
technical/JJ
artifacts/NNS
./.
====================
Based/VBN
on/IN
these/DT
findings/NNS
,/,
we/PRP
propose/VBP
that/IN
chromatin/NN
regulation/NN
mechanisms/NNS
have/VBP
evolved/VBN
a/DT
stable/JJ
genetic/JJ
architecture/NN
while/IN
the/DT
transcription/NN
regulatory/JJ
network/NN
maintains/VBZ
high/JJ
genetic/JJ
complexity/NN
and/CC
connectivity/NN
and/CC
is/VBZ
more/RBR
susceptible/JJ
to/TO
mutations/NNS
./.
====================
First/RB
,/,
the/DT
lower/JJR
number/NN
of/IN
associations/NNS
per/IN
chromatin/NN
trait/NN
suggests/VBZ
that/IN
chromatin/NN
structure/NN
is/VBZ
more/RBR
robust/JJ
to/TO
genetic/JJ
perturbation/NN
./.
====================
On/IN
the/DT
contrary/NN
,/,
gene/NN
expression/NN
traits/VBZ
have/VBP
more/RBR
associations/NNS
,/,
increasing/VBG
the/DT
probability/NN
of/IN
targets/NNS
being/VBG
associated/VBN
with/IN
mutations/NNS
./.
====================
Second/RB
,/,
chromatin/NN
associations/NNS
are/VBP
biased/VBN
to/TO
a/DT
handful/JJ
of/IN
loci/NNS
responsible/JJ
for/IN
an/DT
extremely/RB
large/JJ
number/NN
of/IN
chromatin/NN
sites/NNS
./.
====================
As/IN
long/JJ
as/IN
these/DT
hotspot/NN
loci/NNS
are/VBP
protected/VBN
from/IN
mutations/NNS
,/,
the/DT
perturbation/NN
of/IN
chromatin/NN
regulation/NN
architecture/NN
could/MD
be/VB
minimized/VBN
./.
====================
In/IN
contrast/NN
,/,
the/DT
average/NN
number/NN
of/IN
associations/NNS
is/VBZ
high/JJ
for/IN
transcription/NN
regulatory/JJ
loci/NNS
,/,
increasing/VBG
the/DT
overall/JJ
effect/NN
of/IN
single/JJ
mutations/NNS
./.
====================
Given/IN
the/DT
higher/JJR
probability/NN
of/IN
expression/NN
traits/VBZ
being/VBG
associated/VBN
with/IN
mutations/NNS
and/CC
the/DT
greater/JJR
influence/IN
of/IN
individual/JJ
mutations/NNS
on/IN
transcription/NN
,/,
it/PRP
is/VBZ
conceivable/JJ
that/IN
phenotypic/JJ
diversity/NN
is/VBZ
more/RBR
likely/RB
to/TO
be/VB
created/VBN
in/IN
response/NN
to/TO
genetic/JJ
variation/NN
at/IN
the/DT
level/NN
of/IN
transcription/NN
processes/NNS
downstream/RB
of/IN
chromatin/NN
regulation/NN
steps/NNS
./.
====================
Data/NNS
analysis/NN
scheme/VBP
./.
====================
Relationships/NNS
between/IN
the/DT
genetic/JJ
regulatory/JJ
loci/NNS
and/CC
the/DT
quantitative/JJ
traits/VBZ
(/(
chromatin/NN
accessibility/NN
or/CC
gene/NN
expression/NN
)/)
were/VBD
explored/VBN
in/IN
yeast/NN
and/CC
human/JJ
./.
====================
Data/NNS
from/IN
different/JJ
experimental/JJ
settings/NNS
and/CC
technical/JJ
platforms/NNS
were/VBD
integrated/VBN
into/IN
a/DT
unified/JJ
analytical/JJ
framework/NN
./.
====================
RNA-seq/NN
,/,
RNA-sequencing/JJ
;/:
FAIRE-seq/NN
,/,
Formaldehyde-Assisted/JJ
Isolation/NN
of/IN
Regulatory/JJ
Elements/NNS
followed/VBN
by/IN
sequencing/VBG
;/:
DNase-seq/NN
,/,
DNaseI/NN
hypersensitivity/NN
assay/NN
coupled/VBN
with/IN
high-throughput/JJ
sequencing/NN
;/:
QTL/NN
,/,
quantitative/JJ
trait/NN
loci/NNS
./.
====================
Manhattan/JJ
plots/NNS
displaying/VBG
the/DT
chromosomal/JJ
distribution/NN
of/IN
regulatory/JJ
loci/NNS
and/CC
(/(
x/CC
axis/NN
)/)
and/CC
the/DT
number/NN
of/IN
associations/NNS
for/IN
each/DT
locus/NN
divided/VBN
by/IN
the/DT
total/JJ
number/NN
of/IN
associations/NNS
(/(
i.e./FW
,/,
percentage/NN
on/IN
the/DT
y/JJ
axis/NN
)/)
at/IN
a/DT
given/VBN
p-value/NN
in/IN
human/JJ
(/(
p/NN
</JJR
0.01/CD
)/)
and/CC
yeast/NN
(/(
p/NN
</JJR
0.05/CD
)/)
./.
====================
QTL/NN
,/,
quantitative/JJ
trait/NN
loci/NNS
./.
====================
Manhattan/JJ
plots/NNS
displaying/VBG
the/DT
chromosomal/JJ
distribution/NN
of/IN
target/NN
traits/VBZ
(/(
x/CC
axis/NN
)/)
and/CC
the/DT
number/NN
of/IN
associations/NNS
for/IN
each/DT
trait/VBP
divided/VBN
by/IN
the/DT
total/JJ
number/NN
of/IN
associations/NNS
(/(
i.e./FW
,/,
percentage/NN
on/IN
the/DT
y/JJ
axis/NN
)/)
at/IN
a/DT
given/VBN
p-value/NN
in/IN
human/JJ
(/(
p/NN
</JJR
0.01/CD
)/)
and/CC
yeast/NN
(/(
p/NN
</JJR
0.05/CD
)/)
./.
====================
QTL/NN
,/,
quantitative/JJ
trait/NN
loci/NNS
./.
====================
Box/DT
plots/NNS
showing/VBG
the/DT
percentage/NN
of/IN
associations/NNS
for/IN
each/DT
regulatory/JJ
locus/NN
(/(
upper/IN
)/)
or/CC
quantitative/JJ
trait/NN
(/(
lower/JJR
)/)
from/IN
chromatin/NN
quantitative/JJ
trait/NN
loci/NNS
(/(
QTL/NN
)/)
and/CC
expression/NN
QTL/NN
mapping/VBG
on/IN
a/DT
log/NN
scale/JJ
in/IN
human/JJ
(/(
left/NN
)/)
and/CC
yeast/NN
(/(
right/JJ
)/)
./.
====================
